Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Idorsia
Pharma
Idorsia eyes pediatric insomnia market with ph. 2 win
After a phase 2 trial win, Idorsia’s insomnia med Quviviq is one step closer to potentially becoming a first-in-class treatment for children.
Zoey Becker
Mar 30, 2026 11:25am
Idorsia shares sink after CEO's abrupt departure
Mar 16, 2026 11:00am
Chiesi, Viatris among collaborators on BIO video series
Jul 28, 2025 12:00pm
Idorsia's Tryvio nabs FDA approval following buyback from J&J
Mar 20, 2024 12:40pm
Viatris still hungry for deals after pact with Idorsia: CEO
Feb 28, 2024 10:45am
Sosei ushers in new era with Nxera Pharma name change
Feb 16, 2024 3:30am
